ΔNp63α in cancer: importance and therapeutic opportunities

Matthew L Fisher1, Seamus Balinth2, Alea A Mills1

  • 1Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.

Trends in Cell Biology
|September 17, 2022
PubMed

Insights

Targeting the ΔNp63α isoform may overcome major cancer challenges. Inhibiting this key protein could reduce cancer stem cells, prevent metastasis, and overcome drug resistance, improving patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer research has advanced significantly, yet challenges like targeting cancer stem cells (CSCs), metastasis, and drug resistance persist.
  • The p63 protein, a member of the p53 family, has multiple isoforms with diverse functions.
  • The ΔNp63α isoform plays a critical role in various cancers.

Purpose of the Study:

  • To highlight the importance of the ΔNp63α isoform in cancer.
  • To explore therapeutic strategies targeting ΔNp63α expression.
  • To address key challenges in cancer survival: CSCs, metastasis, and drug resistance.

Main Methods:

  • Literature review and discussion of existing research on p63 isoforms and cancer pathways.
  • Analysis of the role of ΔNp63α in cancer stem cell populations.
  • Exploration of potential therapeutic interventions targeting ΔNp63α.

Main Results:

  • The ΔNp63α isoform is crucial for cancer cell survival and progression.
  • Targeting ΔNp63α presents a promising strategy to inhibit CSCs.
  • Inhibition of ΔNp63α may also prevent metastasis and overcome drug resistance.

Conclusions:

  • The ΔNp63α isoform is a significant therapeutic target in oncology.
  • Developing strategies to inhibit ΔNp63α could lead to improved cancer patient outcomes.
  • Further research into targeting ΔNp63α is warranted to combat critical aspects of cancer progression.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K